Cannabinomics: The Marijuana Policy Tipping Point
A revolutionary new book that reframes the marijuana debate in a new conversation on the public policy task of cannabis management.
From medical renaissance to revolution, from drug war prohibition to public health, from economic reefer madness to recovery--trajectories in public policy are converging toward regulation and economic integration of the herbal cannabis trade.
"Americans are by and large ready for this change now but haven't had the vocabulary to articulate it," writes Cannabinomics author Christopher Glenn Fichtner, M.D., a psychiatrist and former state mental health director.
Cannabinomics is not a medical handbook, a drug war treatise, or an economic model but rather a work of patient and public policy advocacy. It looks at real-world medical cases, recent trends in successful policy reform, drug war costs, and the potential economic benefits of cannabis change.
Cannabinomics calls for a stakeholder-inclusive regulatory process to help America take ownership of this homegrown commodity and facilitate system learning that could help solve larger global drug war problems.